Filing Flows

Filing Flows › Evommune (EVMN) › How it makes money

How Evommune (EVMN) makes money

Evommune (EVMN) made $10.0M of revenue in the third quarter 2025 (Q3 2025).

Drawing the Sankey…

Where each dollar of revenue goes

LineQ3 2025% of revenue
Revenue$10.0M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q3 2025$10.0M—

From Evommune's 10-Q filed Dec 11, 2025 (on EDGAR).

Questions

How does Evommune make money?

Evommune (EVMN) made $10.0M of revenue in the third quarter 2025 (Q3 2025).

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.